Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder

Schizophrenia Research

Volumn 120, Issue 1-3, 2010, Pages 159-166

  Slonimsky, Alexandra ^a   Levy, Itzchak ^b   Kohn, Yoav ^a   Rigbi, Amihai ^a   Ben Asher, Edna ^c   Lancet, Doron ^c   Agam, Galila ^b   Lerer, Bernard ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

AHI1; C6orf217; Gene expression; Schizophrenia

Indexed keywords

ABELSON HELPER INTERGRATION SITE 1; GENE PRODUCT; PROTEIN C6ORF217; UNCLASSIFIED DRUG; AHI1 PROTEIN, HUMAN; IMMUNOGLOBULIN; LY6G6F PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; BRAIN; CELL IMMORTALIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISRAEL; LYMPHOBLAST; MALE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ANALYSIS OF VARIANCE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; LYMPHOCYTE; PATHOLOGY; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; BRAIN; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULINS; LYMPHOCYTES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 77954213029     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.03.041     Document Type: Article

References (30)

1. Alvarez Retuerto A.I., Cantor R.M., Gleeson J.G., Ustaszewska A., Schackwitz W.S., Pennacchio L.A., Geschwind D.H. Association of common variants in the Joubert syndrome gene (AHI1) with autism. Hum. Mol. Genet. 2008, 17:3887-3896.
2. Amann-Zalcenstein D., Avidan N., Kanyas K., Ebstein R.P., Kohn Y., Hamdan A., Ben-Asher E., Karni O., Mujaheed M., Segman R.H., Maier W., Macciardi F., Beckmann J.S., Lancet D., Lerer B. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur. J. Hum. Genet. 2006, 14:1111-1119.
3. Behan A.T., Byrne C., Dunn M.J., Cagney G., Cotter D.R. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol. Psychiatry 2009, 14:601-613.
4. Bennett E.R., Yedgar S., Lerer B., Ebstein R.P. Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients. Biol. Psychiatry 1991, 29:1058-1062.
5. Dixon-Salazar T., Silhavy J.L., Marsh S.E., Louie C.M., Scott L.C., Gururaj A., Al-Gazali L., Al-Tawari A.A., Kayserili H., Sztriha L., Gleeson J.G. Mutations in the AHI1 gene, encoding jouberin, cause Joubert syndrome with cortical polymicrogyria. Am. J. Hum. Genet. 2004, 75:979-987.
6. Doering J.E., Kane K., Hsiao Y.C., Yao C., Shi B., Slowik A.D., Dhagat B., Scott D.D., Ault J.G., Page-McCaw P.S., Ferland R.J. Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies. J. Comp. Neurol. 2008, 511:238-256.
7. Eley L., Gabrielides C., Adams M., Johnson C.A., Hildebrandt F., Sayer J.A. Jouberin localizes to collecting ducts and interacts with nephrocystin-1. Kidney Int. 2008, 74:1139-1149.
8. Ferland R.J., Eyaid W., Collura R.V., Tully L.D., Hill R.S., Al-Nouri D., Al-Rumayyan A., Topcu M., Gascon G., Bodell A., Shugart Y.Y., Ruvolo M., Walsh C.A. Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat. Genet. 2004, 36:1008-1013.
9. Ingason A., Sigmundsson T., Steinberg S., Sigurdsson E., Haraldsson M., Magnusdottir B.B., Frigge M.L., Kong A., Gulcher J., Thorsteinsdottir U., Stefansson K., Petursson H., Stefansson H. Support for involvement of the AHI1 locus in schizophrenia. Eur. J. Hum. Genet. 2007, 15:988-991.
10. Ingason, A., Giegling, I., Cichon, S., Hansen, T., Rasmussen, H. B., Nielsen, J., Jurgens, G., Muglia, P., Hartmann, A. M., Strengman, E., Vasilescu, C., Muhleisen, T. W., Djurovic, S., Melle, I., Lerer, B., Moller, H. J., Francks, C., Pietilainen, O. P., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Walshe, M., Vassos, E., Di Forti, M., Murray, R., Bonetto, C., Tosato, S., Cantor, R. M., Rietschel, M., Craddock, N., Owen, M. J., Peltonen, L., Andreassen, O. A., Nothen, M. M., St Clair, D., Ophoff, R. A., O'Donovan, M. C., Collier, D. A., Werge, T., Rujescu, D., 2010. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Human Molecular Genetics 19, 1379-1386.
11. Jiang X., Hanna Z., Kaouass M., Girard L., Jolicoeur P. Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations. J. Virol. 2002, 76:9046-9059.
12. Kirov G., Zaharieva I., Georgieva L., Moskvina V., Nikolov I., Cichon S., Hillmer A., Toncheva D., Owen M.J., O'Donovan M.C. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol. Psychiatry 2009, 14:796-803.
13. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 2007, 16:129-141.
14. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., Harrison P.J., Kleinman J.E., Weinberger D.R. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc. Natl Acad. Sci. USA 2006, 103:6747-6752.
15. Lencz T., Morgan T.V., Athanasiou M., Dain B., Reed C.R., Kane J.M., Kucherlapati R., Malhotra A.K. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol. Psychiatry 2007, 12:572-580.
16. Lerer B., Segman R.H., Hamdan A., Kanyas K., Karni O., Kohn Y., Korner M., Lanktree M., Kaadan M., Turetsky N., Yakir A., Kerem B., Macciardi F. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol. Psychiatry 2003, 8:488-498.
17. Levi A., Kohn Y., Kanyas K., Amann D., Pae C.U., Hamdan A., Segman R.H., Avidan N., Karni O., Korner M., Jun T.Y., Beckmann J.S., Macciardi F., Lerer B. Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval. Eur. J. Hum. Genet. 2005, 13:763-771.
18. Luoma S., Hakko H., Ollinen T., Jarvelin M.R., Lindeman S. Association between age at onset and clinical features of schizophrenia: the Northern Finland 1966 birth cohort study. Eur. Psychiatry 2008, 23:331-335.
19. Mah S., Nelson M.R., Delisi L.E., Reneland R.H., Markward N., James M.R., Nyholt D.R., Hayward N., Handoko H., Mowry B., Kammerer S., Braun A. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol. Psychiatry 2006, 11:471-478.
20. Nicodemus K.K., Law A.J., Luna A., Vakkalanka R., Straub R.E., Kleinman J.E., Weinberger D.R. A 5' promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression. Mol. Psychiatry 2009, 14:741-743.
21. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40:1053-1055.
22. Parisi M.A., Doherty D., Chance P.F., Glass I.A. Joubert syndrome (and related disorders) (OMIM 213300). Eur. J. Hum. Genet. 2007, 15:511-521.
23. Parisi M.A., Doherty D., Eckert M.L., Shaw D.W., Ozyurek H., Aysun S., Giray O., Al Swaid A., Al Shahwan S., Dohayan N., Bakhsh E., Indridason O.S., Dobyns W.B., Bennett C.L., Chance P.F., Glass I.A. AHI1 mutations cause both retinal dystrophy and renal cystic disease in Joubert syndrome. J. Med. Genet. 2006, 43:334-339.
24. Renou J., De Luca V., Zai C.C., Bulgin N., Remington G., Meltzer H.Y., Lieberman J.A., Le Foll B., Kennedy J.L. Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia. Mol. Psychiatry 2007, 12:1058-1060.
25. Sheng G., Xu X., Lin Y.F., Wang C.E., Rong J., Cheng D., Peng J., Jiang X., Li S.H., Li X.J. Huntingtin-associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice. J. Clin. Investig. 2008, 118:2785-2795.
26. Shi Z., Liang N., Xu W., Li K., Sheng G., Liu J., Xu A., Li X.J., Wu D. Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the SH3 domain of human AHI1. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2009, 65:361-363.
27. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., Owen M.J., Walsh D., Weinberger D.R., Sun C., Flint J., Darvasi A. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 2008, 4:e28.
28. Sullivan P.F., Lin D., Tzeng J.Y., van den Oord E., Perkins D., Stroup T.S., Wagner M., Lee S., Wright F.A., Zou F., Liu W., Downing A.M., Lieberman J., Close S.L. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry 2008, 13:570-584.
29. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
30. Yu F., Keinan A., Chen H., Ferland R.J., Hill R.S., Mignault A.A., Walsh C.A., Reich D. Detecting natural selection by empirical comparison to random regions of the genome. Hum. Mol. Genet. 2009, 18:4853-4867.